Aptamers are short strands of nucleic acids with high affinity and specificity for their targets. Advantages of using aptamers, relative to antibodies, include their smaller size, ease of synthesis, and lack of immunogenicity. Therefore, aptamers technology can be a novel cancer therapy strategy. The goals of our research program are to develop aptamers that catch and release circulating tumor cells and block receptors involve in cancer stem cell pathways.